###
中国临床研究:2026,39(8):1186-1191
本文二维码信息
码上扫一扫!
能谱增强CT联合血清lncRNA HOXA-AS2、miR-485-5p对胃癌患者淋巴结转移的预测价值
(1. 联勤保障部队第九四○医院医学工程科, 甘肃 兰州 730050;2. 白银市第一人民医院消化内科, 甘肃 白银 730900;3. 白银市第一人民医院放射治疗科, 甘肃 白银 730900)
Predictive value of spectral-enhanced CT combined with serum lncRNA HOXA-AS2 and miR-485-5p for lymph node metastasis in gastric cancer patients
摘要
本文已被:浏览 213次   下载 264次
投稿时间:2025-09-12   网络发布日期:2026-08-25
中文摘要: 目的 探讨能谱增强CT成像联合血清长链非编码RNA同源盒基因A-反义链2(lncRNA HOXA-AS2)、微小RNA(miR)-485-5p预测胃癌患者淋巴结转移(LNM)的价值,为术前评估和诊疗决策提供参考。方法 回顾性选取2021年12月至2024年12月联勤保障部队第九四○医院进行手术治疗的118例胃癌患者,根据术后病理结果,将患者分为LNM组(n=74)和无LNM组(n=44)。所有患者术前均接受能谱增强CT扫描,检测入院24 h内血清lnc-RNA HOXA-AS2和miR-485-5p的表达水平,并进行两组间对比。三种检测与病理结果的一致性采用Kap-pa指数评价。胃癌患者LNM的影响因素用logistic回归分析。三种检测对胃癌发生LNM的预测价值用受试者工作特征(ROC)曲线评估。结果 LNM组血清HOXA-AS2水平比无LNM组升高,miR-485-5p水平降低(P<0.05)。与无LNM组对比,LNM组的能谱定量参数值、能谱增强CT所示病灶周围脂肪模糊毛糙的比例及胃镜提示浸润达黏膜下层比例更高(P<0.05),血清lncRNA HOXA-AS2高表达、miR-485-5p低表达均为胃癌患者LNM的危险因素(P<0.05)。能谱增强CT、血清lncRNA HOXA-AS2、miR-485-5p检测及三者联合与病理结果一致性的Kappa值分别为0.530、0.472、0.436 和0.651(P<0.01),预测胃癌LNM 的曲线下面积(AUC)分别为0.776、0.801、0.832 和0.924,三者联合较单一预测效果更佳[Z(联合vs lncRNA HOXA-AS2)=2.726,P=0.006;Z(联合vs miR-485-5p)=1.987,P=0.047;Z(联合vs CT)=3.230,P=0.001]。结论 血清lncRNA HOXA-AS2 高表达和miR-485-5p 低表达与胃癌患者LNM 的发生密切相关,能谱增强CT联合血清两指标的检测对胃癌患者LNM的预测价值较高,三者联合应用,有助于患者预后的预测和临床诊疗方案的制定。
Abstract:Objective To explore the value of spectral-enhanced CT imaging combined with serum long non-coding RNA homeobox A-antisense strand 2(lncRNA HOXA-AS2)and microRNA (miR)-485-5p in predicting lymph node metastasis(LNM)in gastric cancer patients,and to provide references for preoperative evaluation,diagnosis and treatment decision. Methods A retrospective study was conducted on 118 patients with gastric cancer who underwent surgical treatment at the 940th Hospital of Joint Logistics Support Force from December 2021 to December 2024. Based on postoperative pathological results,the patients were assigned into LNM group(n=74)and non-LNM group(n=44).All patients underwent spectral-enhanced CT scanning before surgery,and the expression levels of serum lncRNA HOXA-AS2 and miR-485-5p within 24 hours of admission were detected,with a comparison between the two groups being carried out. The consistency of the three tests with pathological results was evaluated using Kappa index. The influencing factors of LNM in gastric cancer patients were analyzed using logistic regression analysis. The predictive value of the three tests for LNM occurrence in gastric cancer was evaluated using receiver operating characteristic(ROC)curves. Results Compared with the non-LNM group,the serum HOXA-AS2 level in the LNM group was higher,while the miR-485-5p level was lower(P<0.05). Compared with the non-LNM group,the LNM group had higher values of spectral quantitative parameters,the higher proportion of fuzzy and rough fat around the lesion as shown by spectral-enhanced CT,and the higher proportion of submucosal infiltration as suggested by gastroscopy(P<0.05). High expression of serum lncRNA HOXA-AS2 and low expression of miR-485-5p were both risk factors for LNM in gastric cancer patients(P<0.05). The Kappa values for the consistency between spectral-enhanced CT,serum lncRNA HOXA-AS2,miR-485-5p detection,and their combination with pathological results were 0.530,0.472,0.436,and 0.651(P<0.01),respectively. The areas under the curve(AUC)for predicting gastric cancer LNM were0.776,0.801,0.832,and 0.924,respectively,with the combination of all three showing better predictive performance than each alone[Z(combined vs lncRNA HOXA-AS2)=2.726,P=0.006;Z(combined vs miR-485-5p)=1.987,P=0.047;Z(combined vs CT)=3.230,P=0.001]. Conclusion High expression of serum lncRNA HOXA-AS2 and low expression of miR-485-5p are closely related to the occurrence of LNM in gastric cancer patients. The combined detection of these two serum indicators with spectral-enhanced CT has a high predictive value for LNM in gastric cancer patients. The joint application of the three can help in the prediction of patient prognosis and the formulation of clinical diagnosis and treatment plans.
文章编号:     中图分类号:R735.2    文献标志码:A
基金项目:
附件
引用文本:
包其扬,刘海龙,黄永辉.能谱增强CT联合血清lncRNA HOXA-AS2、miR-485-5p对胃癌患者淋巴结转移的预测价值[J].中国临床研究,2026,39(8):1186-1191.

用微信扫一扫

用微信扫一扫